Study in Parkinson's Disease Patients with Dyskinesia with Combinations of JM-010 and Its Individual Components (SHINE)

General Information

Age Group




Protocol Number


Background Information

Research Question: To compare the efficacy of the study medication to that of placebo therapy in reducing dyskinesia severity in Parkinson's disease.

Offered At

Inova Medical Group – Neurology
8081 Innovation Park Dr., #900
Fairfax, VA 22031

Eligibility Information

  • Adults, between 18 and 80 years of age at screening visit
  • Is diagnosed with idiopathic PD that meets UK Parkinson's Disease Society (UKPDS) Brain Bank Clinical Diagnostic Criteria
  • Has experienced dyskinesia
  • Has stable peak-effect dyskinesia
  • Has more than one hour of "ON" time with troublesome dyskinesia

Ineligibility Information

  • Has undergone surgery for the treatment of PD
  • Has a current diagnosis of substance use
  • Has psychiatric diagnosis of acute psychotic disorder or other psychiatric diagnoses
  • Has current seizure disorders requiring treatment with anticonvulsants.

Additional information can be found at: